Final Interviews for Territory Leaders (Sales)?

[anonymous]

Why would the patients freak out?

You know nothing about this product and what it is for because if you did you would not have asked that question

 

[anonymous]

You know nothing about this product and what it is for because if you did you would not have asked that question

an eye drop that is designed to eradicate the Demodex mites, which are too small to see with the naked eye. given as a single drop OU BID for six weeks. and will have a wholesale acquisition cost of $1,850 per prescription… what am I missing?

 

[anonymous]

an eye drop that is designed to eradicate the Demodex mites, which are too small to see with the naked eye. given as a single drop OU BID for six weeks. and will have a wholesale acquisition cost of $1,850 per prescription… what am I missing?

Great assessment! Only thing you missed is no symptom relief. That would mean another drug!

 

[anonymous]

an eye drop that is designed to eradicate the Demodex mites, which are too small to see with the naked eye. given as a single drop OU BID for six weeks. and will have a wholesale acquisition cost of $1,850 per prescription… what am I missing?

Just use tea tree oil. It works fine.

 

[anonymous]

Tarsus is the next Apellis. We are all doomed!

 

[anonymous]

an eye drop that is designed to eradicate the Demodex mites, which are too small to see with the naked eye. given as a single drop OU BID for six weeks. and will have a wholesale acquisition cost of $1,850 per prescription… what am I missing?

$1,850! You can just get the dog version for 20 bucks! This is what is wrong with the pharmaceutical industry.

 

[anonymous]

Tarsus is the next Apellis. We are all doomed!

Apellis is setting the bar a bit high for Tarsus. It’s funny they think they have a billion dollar product on their hands. I’d be shocked if they hit 50 mil at their peak.

 

[anonymous]

Going to be a big hurdle. One and done? What is the relapse rate? Payers wont' pay twice if out of the gate don't see cure going to be hard to recover. How many pts are really in the cue and what is the cadence of a pt. Direct to patient has not proven much success in other areas ROI. This is not Linzess where there was some good return. No take out on this one for 2 years unless they prove quickly that the product works

 

[anonymous]

$1,850! You can just get the dog version for 20 bucks! This is what is wrong with the pharmaceutical industry.

Wow, it’s true. I looked it up and the price for dogs is 20 dollars for the same medicine. Why pay $1,850?

 

[anonymous]

Couldn't get them to pay me $135K. Have 15 years in eyecare, great track record.

 

[anonymous]

Most 15 year eyecare reps I know suck.

 

[anonymous]

Eyecare reps are not worth 135. Especially for treating Eye Crabs.